Every so often, a news story comes along that captures people’s attention, stirs curiosity, and sparks conversation. Recently, CNN featured one such story about a young boy named Mason, his journey with autism, and a decades-old drug called leucovorin that brought his family a ray of hope.
Before we go further, we want to be absolutely clear: this blog is not medical advice. We are not endorsing or discouraging the use of any medication. This is simply a retelling of a publicly available news story. Autism is a complex and varied condition, and every child’s experience is unique. What worked for one child may not work for another.
We invite you to read this as just that — a story.
A Mother’s Concern and a Long Search for Answers
Caroline Connor began to worry about her son Mason’s development when he was just a year old. She noticed he wasn’t speaking — not even a few words — when most toddlers begin to use language. Their pediatrician reassured her that some children develop speech later, and there was no need for alarm. But as the months went on, Mason’s speech delay persisted.
By the time Mason was two and a half, Caroline’s concerns had deepened. Mason wasn’t catching up in language skills, and she was noticing other differences in his development. After a series of evaluations, Mason was diagnosed with autism spectrum disorder (ASD).
Like many parents in her situation, Caroline began a relentless search for ways to support her son’s growth and communication. She and her husband Joe researched therapies, read articles, joined online support groups, and explored different medical and developmental interventions.
It was during this search that they came across a name that kept appearing in research papers and online discussions: Dr. Richard Frye, a pediatric neurologist known for studying a little-known connection between folate metabolism and autism.
An Old Drug in a New Light
Dr. Frye was researching leucovorin, a generic drug derived from folic acid (vitamin B9). For decades, leucovorin has been used in medicine to help reduce side effects of certain cancer treatments. Pregnant women, meanwhile, are often advised to take folic acid supplements to prevent neural tube defects in developing babies.
But Frye and other researchers suspected leucovorin might have another potential use — one that had little to do with cancer treatment and much to do with brain development.
The Science of Cerebral Folate Deficiency
Their work focused on a condition called cerebral folate deficiency (CFD). In CFD, the level of folate in the brain is abnormally low, even though blood tests show normal folic acid levels. This puzzled researchers until they discovered a possible cause: autoantibodies against the folate receptor alpha (FR⍺).
The FR⍺ acts like a gateway, transporting folate from the blood into the brain and across the placenta during pregnancy. But in some people, the immune system mistakenly creates antibodies that block this receptor. Without enough folate in the brain during critical stages of development, neurological problems can occur.
Dr. Frye and his colleagues found that these autoantibodies appear in a high percentage of children with autism spectrum disorder — in one study, over 75% of autistic children tested positive, compared to 10–15% of typically developing children.
When the FR⍺ is blocked, the brain still has a backup pathway called the reduced folate carrier (RFC). This transporter is less efficient but can carry leucovorin — the active form of folic acid — into the brain. Once inside, enzymes convert leucovorin into the biologically active form of folate that the brain needs.
This led researchers to wonder: could leucovorin supplementation improve symptoms in children with autism who have CFD?
What the Studies Show So Far
A small number of randomized controlled trials — in the U.S., France, and India — have suggested that leucovorin treatment may help improve speech and communication in some children with autism. In one study, about one-third of children experienced noticeable improvements in speech and other behaviors.
Side effects were generally mild, with some children experiencing temporary hyperactivity during the first few weeks of treatment. This pattern is also seen with other B-vitamin supplements.
Still, all the researchers emphasize that leucovorin is not a cure for autism. It may help a subset of children — particularly those with confirmed FR⍺ autoantibodies — but it is far from a universal solution. And because these studies have been small, much larger trials are needed to confirm the benefits.
Mason’s “Little Bottle of Hope”
For the Connors, the decision to try leucovorin came after much reading and discussion with medical professionals. Mason began taking the medication at the age of three.
Three days later, according to his parents, Mason spoke his first words. Over the following weeks and months, they noticed changes in his ability to communicate and interact. By age five, Mason was preparing to start mainstream kindergarten — something his parents had once wondered if he would be able to do.
They refer to leucovorin as Mason’s “little bottle of hope,” though they acknowledge that it may not have the same effect for every child.
Why Isn’t This a Common Treatment?
One reason is that leucovorin’s use for autism is off-label — meaning it’s not specifically approved by the U.S. Food and Drug Administration (FDA) for that purpose. While doctors can legally prescribe medications off-label, they typically do so when there’s enough evidence to believe the benefits outweigh the risks.
Another reason is financial: leucovorin is a decades-old generic drug that sells for a low price. Large pharmaceutical companies have little incentive to fund expensive, large-scale clinical trials for a medication that won’t generate significant profit.
Dr. Frye and other researchers would like to see more funding for large studies that could lead to FDA approval. But for now, the lack of big-money backing means progress is slow.
The Role of Every Cure
One group trying to change this is Every Cure, a nonprofit that uses artificial intelligence to find new uses for existing drugs. The group’s founder, Dr. David Fajgenbaum, has a personal stake in this work — he credits a repurposed drug with saving his own life after he was diagnosed with a rare, life-threatening disease.
Fajgenbaum believes the healthcare system often overlooks valuable treatments simply because they are old, inexpensive, and unprofitable. “It’s heartbreaking to think about drugs being on the pharmacy shelf while someone suffers from a disease,” he told CNN.
Every Cure has brought attention to Frye’s work and hopes to push forward research that might otherwise be left behind.
Important Points to Remember
Before anyone considers leucovorin or any other treatment mentioned in a news story, a few things need to be made crystal clear:
- This is not medical advice.
Every child is unique, and treatments that help one may not help another. - Leucovorin is not FDA-approved for autism.
It is only prescribed off-label in some cases. - Research is still in the early stages.
The studies so far have been small. Large, definitive trials are needed. - Medical decisions should only be made with qualified healthcare professionals.
Never start or change treatment without professional guidance.
Taking the Story as Just a Story
The world of autism research is vast and constantly evolving. Families all over the globe are exploring different therapies, both mainstream and experimental, in the hope of finding something that makes a difference for their child. Some find help in unexpected places. Others try promising avenues that don’t pan out.
Mason’s story is one family’s journey. It’s a story about persistence, curiosity, and the hope that science can offer. But it’s not a universal prescription, and it’s not a guarantee.
Final Thoughts
Stories like Mason’s can inspire, inform, and raise awareness about lesser-known aspects of medical research. They can also remind us that there’s much about autism we still don’t fully understand — and that science, for all its advances, still holds many unanswered questions.
For families navigating autism, the journey can be overwhelming, filled with trial and error. In sharing this story, our goal is not to suggest a path, but to highlight the importance of keeping an open mind while also remaining cautious.
If you’re curious, you can read CNN’s full article for more details. But remember: in health matters, there is no substitute for personalized medical advice from a trusted professional.
For now, we take this story for what it is — an interesting piece of reporting, a glimpse into one family’s experience, and a reminder that hope can take many forms.
At Aim Higher ABA Therapy, our experienced team provides individualized consultation and intervention services that enable children with autism to learn and thrive.
FAQs
What is applied behavior analysis (ABA) and how does it help children with autism?
Applied behavior analysis (ABA) is a scientifically validated approach used to improve specific behaviors such as communication, social skills, and adaptive learning. For children with autism, ABA focuses on breaking down tasks into small, manageable steps and reinforcing positive behaviors. Many parents searching for “applied behavior analysis near me” do so to find local therapy that can help their children gain essential life skills.
Can medication help nonverbal children with autism start speaking?
In certain clinical settings, some medications have shown potential to help children stay more engaged, focused, and receptive to learning. However, we do not recommend medication as a treatment option unless it is prescribed and supervised by a qualified healthcare provider. Medication alone does not teach speech, but when used under medical guidance, it may support the outcomes of evidence-based interventions like ABA.
How can I find trusted ABA clinics near me?
To find reliable aba clinics near me, start by researching centers with board-certified behavior analysts (BCBAs), strong parent reviews, and customized treatment plans. It’s important to visit the clinic, ask about success stories, and ensure they involve parents in the therapy process.
What age is best to start ABA therapy for a nonverbal child?
Early intervention is key. Starting ABA therapy before the age of five can significantly improve communication, cognitive, and social outcomes. If you’re noticing developmental delays, consider searching for applied behavior analysis near me as early as possible to begin intervention.
How does ABA therapy support speech development in nonverbal children?
ABA therapy helps nonverbal children with autism by using reinforcement, imitation, and prompting techniques. Therapists may start with gestures or visual cues and gradually introduce sounds and words. Consistency and repetition help children associate words with actions, leading to functional communication.
What are some signs that ABA therapy is working?
Signs of progress include improved eye contact, reduced tantrums, increased use of gestures or words, better attention span, and following simple instructions. Parents often notice subtle changes first, which grow over time with continued support from professionals at trusted aba clinics near me.
Is it necessary for parents to be involved in their child’s ABA sessions?
Yes, parent involvement is crucial for success. Therapists often provide parent training so that the strategies used in therapy can be applied at home. This helps reinforce new skills and ensures continuity of care beyond the therapy sessions.
Can ABA therapy be customized for my child’s unique needs?
Absolutely. A reputable provider offering applied behavior analysis near me will conduct thorough assessments to develop a personalized treatment plan. This plan will address your child’s strengths, challenges, and goals — whether focused on speech, behavior, or social skills.
Note: The information provided in this article is based on current research and should not be considered medical advice. Always consult with a healthcare professional before making decisions regarding treatment options for your child.
References
- CBS News. (2023). New autism drug shows promise in helping nonverbal children speak. Available at: https://www.cbsnews.com/news/autism-leucovorin-medicine-folic-acid/
Previous Post 
Leave Your Comment